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Abstract Breastfeeding is regarded as the ideal way to nourish infants. However, feeding
with formula milk is also common in much of the West. Despite this, the function
of the molecular components of breast and formula milks are not fully understood,
less still the relationship between the composition of the milk and the infant’s
metabolism and how this influences the infant’s development. The Biotechnology
and Biological Sciences Research Council-funded project ‘The validation of
biomarkers of metabolic efficacy in infant nutrition’ aims to identify lipid
biomarkers that can be used to study the effect of diet on growth and development
of infants. In this work, we have been able to validate these markers. Here, we
present an approach to biomarker discovery that has new depth and will inform
research questions about how metabolism is governed, and which species can be
used to identify situations where metabolism is becoming defective.
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Introduction
The national and international guidelines for infant
nutrition recommend breastfeeding (WHO 2007,
2009) and it is widely regarded as an important part
of the best start to a baby’s life. This consensus has
led to the recommendation that babies are breastfed
exclusively for the first 6 months, followed by a tran-
sitional period of a year or more to establish feeding
on solid foods as currently advised by the National
Health Service (NHS) in the UK (NHS Choices 2018).
However, it is not always possible to breastfeed exclu-
sively, and so formula milk and other sources of nutri-
tion are used. This variety of feeding regimes and the
evidence for considerable malnutrition in infants in
some areas (IFPRI 2016), coupled with the variety of
growth and development trajectories of children, sug-
gests that there is much still to learn about the
relationship between feeding and infant development.
The traditional approach has been to determine the
total lipid and fat concentration in milk and track the
children’s development. However, the mixture of
lipids and fats in the diet of the infant, combined with
endogenous biosynthesis of lipids and fats, leads to a
complicated profile of lipids in the circulation of the
infant. Furthermore, these molecular species have a
role in growth and development. A lack of under-
standing about how the lipid and fat composition of
the diet affects infant development also limits under-
standing of the effect of the maternal diet and lifestyle
on these processes. The detailed analysis of the circu-
lating lipid profile of the infant, using lipid profiling
techniques, allows investigation into how diet influ-
ences the circulating lipids and whether these are asso-
ciated with the infants’ growth and development.
Lipid profiling, also known as lipidomics, typically
uses mass spectrometry to measure the concentration
of all detectable lipids in a sample simultaneously.
This technique can yield information on several hun-
dred species and relies on advanced data processing
and analysis to determine how lipid profiles differ
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between, for example, breastfed and formula-fed
infants (Koulman et al. 2014).
The lipids and fats in the diets of infants early in life
are of particular importance as they provide a rich
source of energy and raw materials, such as membrane
components, indicating that they have a crucial role in
supporting metabolic activity of this period. Current
understanding of the lipid and fat profile of milk is
basic and typically focused on fatty acids and total
triglyceride levels (Pons et al. 2000; Mitoulas et al.
2002, 2003; Morera et al. 2003; Mandel et al. 2005;
McAnoy et al. 2005; Lısa et al. 2009; Molto-
Puigmartı et al. 2011; Linderborg et al. 2014). It is
not clear how the profile of triglycerides changes with
diet, ethnicity or through the period of lactation. Rela-
tively little is known about the phospholipid fraction,
particularly the anionic lipids. Furthermore, there is
little information on the sterols in human breastmilk.
It is, therefore, not known whether certain species are
essential for healthy growth or are only associated
with poor growth.
In order to investigate this, a comprehensive profil-
ing of fats, lipids and sterols is required. This
approach requires the analysis of a large number of
possible molecular species (we profile around up to
4000). However, only a handful of these may be sig-
nificant in directing the trajectory of an infant’s devel-
opment. At the same time, due to obvious ethical
reasons, blood sampling will often be limited to heel
pricks, yielding dried blood spots, which limit the
number of lipids that can be measured robustly. It is
therefore the aim of the Biotechnology and Biological
Sciences Research Council (BBSRC)-funded project
‘The validation of biomarkers of metabolic efficacy in
infant nutrition’ to develop an assay capable of identi-
fying and quantifying those lipids that can be used as
biomarkers. In addition, the project aims to demon-
strate which lipid and triglyceride species are impor-
tant in relation to infant nutrition, growth and
development; this relies upon proper validation of
those biomarkers. Validation in this context refers to
using a second cohort in order to check the results
(candidate biomarkers) of the first, and their relation-
ship with the effect(s) of interest.
Strategy for using validation in metabolic
studies
Generally, omics-based studies adopt the approach of
measuring very many components in small sample num-
bers. Many research groups find large sample numbers
experimentally challenging in omics-based experiments.
The imbalance between sample numbers and analyte
numbers can lead to the identification of associations
without a clear understanding of whether these relation-
ships are robust. In the last decade, it has emerged that
not all the associations identified in omics studies could
be repeated and for the majority there have been no
attempts to repeat or validate the discoveries. This is
partly due to the prohibitive cost of omics-based stud-
ies. Moreover, only a few strategies for validation have
been suggested, few of which have themselves been vali-
dated, suggesting that a ‘go-to’ structure for establishing
repeatability does not yet exist.
Validation of biomarkers requires that a precise
relationship between the presence or abundance of
that biomarker and the observed effect is evident. The
first step is to embark on a pilot study. This set of
samples forms the discovery samples set, they are the
samples used for the discovery of candidate biomark-
ers. This discovery set (pilot study) needs to be
selected carefully in order to contain sufficient partici-
pants for the effects to be seen clearly. This approach
is aimed at highlighting proto-candidate biomarkers.
Statistical approaches are used on the results from the
discovery set to identify species whose abundance dif-
fers (candidate biomarkers) and correlate (either pro-
portionally or inversely) with the effect.
The approach we favour builds on this first step by
using it to inform the analysis of a second cohort that
is distinct from the first but comparable to it. For
example, a study of a cohort of breastfeeding-only
mother and baby pairs from The Gambia might be
followed up by a cohort of breastfeeding-only mother
and baby pairs from South Africa. Another example
would be a study of a cohort of mixed-fed babies born
to Caucasian parents in Cambridge that might be fol-
lowed up by a cohort with a similar feeding pattern
from Denmark.
This ‘dual-cohort’ approach offers the means for
identifying biomarkers and includes the element of
repeating measurements, but in a way that offers an
objective test. This provides a solution to concerns
raised about repeatability and thoroughness in pre-
clinical research (Macleod 2011; Yong 2012; Russell
2013), while also being scientifically informative. The
dual-cohort approach is more challenging for the dis-
covery of biomarkers, as it is mostly based on studies
with healthy participants that are not under strict
metabolic control and are free-living. This will mean
considerable variation between the samples. Thus,
where results indicate the presence of candidate
biomarkers consistently, they are therefore likely to be
most robust.
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Early results of the ‘validation of
biomarkers of metabolic efficacy in infant
nutrition’ project
The first project we carried out using a dual-cohort
approach was aimed at the discovery of robust lipid
biomarkers for the relationship between infant lipid
metabolism and type of milk feeding – either fully
breastfed, fully formula-fed or receiving a mixture of
both formula and breastmilk. We have developed a
robust method to determine the circulating lipid com-
position of infants using dried blood spot samples
(Koulman et al. 2014). This method was applied to
samples from the Cambridge Baby Growth Study
(Petry et al. 2007; Lu et al. 2016) and we found that
a limited number of circulating lipids were able to
distinguish breastfed from formula-fed infants at
3 months post-partum (Prentice et al. 2015). We fol-
lowed these findings up in two smaller cohort studies
that would give us the opportunity to determine
whether these lipids were indeed biomarkers of infant
nutrition. From this work, we were able to identify
and validate three lipids: a phosphatidylcholine (PC)
with two fatty acid residues that comprise 35 carbons
and two double bonds [PC(35:2)] and two sphin-
gomyelins (SM) SM(36:2) and SM(39:1) that could be
used collectively as biomarkers for infant nutrition
during early development. Through the validation we
were able to show that these biomarkers can be used
to determine whether young infants (3–6 months) are
breastfed or receive formula milk, and even whether
an infant is fed a mixture of both (Acharjee et al.
2017).
We have also adopted the dual-cohort approach in
our work on identifying biomarkers for infant growth.
We published evidence that the presence of several
lipid and triglyceride isoforms have a relationship with
baby weight (Prentice et al. 2015). PC(18:1/16:0) and
PC-O(34:1) correlated with weight gain, where PC
(20:4/18:0), PC-O(36:4), PC(36:4) and SM(d18:2/
16:0) were inversely proportional to weight gain
(Koulman et al. 2014; Prentice et al. 2015). In order
to validate these candidate biomarkers formally, we
have used a cohort of mother-and-baby pairs, this
time from The Gambia. This cohort differs from the
first in that it comprises only exclusively breastfed
infants, has a different ethnicity profile and samples
are drawn from a different region. This means that
the mothers have different diet and living conditions.
Furthermore, sample collection methods differed (the
first study used dried blood and milk spots, the second
fresh plasma and milk samples). Early results from the
Gambian cohort indicate that the measurements taken
in the first set are repeatable. The abundance of
cholesterol and cholesteryl esters is also similar, as is
the isoform profiles of PCs and triglycerides.
Our dual-cohort approach differs from a like-
for-like repetition that has been advocated by psychol-
ogists (Yong 2012). The latter method undoubtedly
has merits, but we argue that our approach is scientifi-
cally relevant and ideal for the type of hypothesis we
wish to test. First, our approach indicates that the
effects we observe are not an artefact of the sampling
methods used, or the ethnicities of the cohort. Second,
the geographically distinct cohorts widen our under-
standing of the practise of breastfeeding, allowing sub-
tler effects to be observed and thus widening the
breadth of the study. Third, it informs the magnitude
of evidence for or against general effects. For example,
data from both of the cohorts described vide supra
broadly support the conclusion that de novo lipid and
triglyceride biosynthesis in mammary glands is consid-
erable (Hansen et al. 1984; McManaman 2009;
Mohammad et al. 2014).
Future perspectives
Current evidence suggests that the dual-cohort
approach is fit-for-purpose for the validation of candi-
date biomarkers. The approach is broad as the mark-
ers identified could be for dietary intake, nutritional
status as well as for health, disease or development. It
also provides an approach that a variety of researchers
can use to assess and validate candidate biomarkers,
in the design of omics-based projects. The concept of
the dual-cohort approach may also find use outside of
life sciences research where validation is required, such
as studies in sociology and psychology, and may also
be used in physical sciences to explore effects observed
in a number of independent systems.
However, further work is required to make it possi-
ble to apply this approach to any other study. For
example, it is important to understand which parame-
ters can be changed and by how much. There is a
clear trade-off between the risk of finding no effect –
which can miss possible biomarkers – and the need
for more work to validate the markers identified. The
scientific value is in producing evidence that demon-
strates that a given effect is (surprisingly) independent
of parameters that seem relevant on paper. This may
not be predictable in advance. For example, a trivial-
sounding procedure, such as sample handling and lipid
extraction, may require more care than expected
(Furse et al. 2015).
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In order to explore the relationship between feed-
ing and infant development, maternal and infant
plasma samples are required, along with breastmilk
and faecal samples. All these samples must be han-
dled in a way that is sympathetic to the presence of
factors that damage the lipid fraction or may bias it.
For example, plasma samples tend not to contain
bacterial cells, which can both produce and destroy
lipids, though faecal samples will. However, plasma
samples may be richer in lipases that remain active
ex vivo, thus altering the lipid profile of the sample
after collection. Approaches to sample handling and
processing differ considerably between research
groups and studies, too. Meta-analyses indicate that
this can have a considerable impact on the relative
and absolute abundance of lipids that is recorded and
published (Furse et al. 2015). A similar effect has
been observed in lipid isolation procedures, leading
to the development of new methods (Furse et al.
2017). This hints that there are features of studies
that cannot be altered if they are to be comparable,
and thorough validation of methods used is necessary
to minimise the risk of this.
We, therefore, suggest that the dual-cohort
approach represents a good testing structure that can
be tailored for the needs of individual scientific ques-
tions. In the context of infant nutrition, this approach
is able to identify candidate biomarkers that may be
involved in shaping infant growth. This may be
important in developing our understanding of how
infant growth is governed and informing feeding
regimes for infants who cannot or should not be
breastfed as well as the relationship between feeding
and development in healthy individuals.
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